Literature DB >> 18556574

Enhanced cellular uptake of remnant high-density lipoprotein particles: a mechanism for high-density lipoprotein lowering in insulin resistance and hypertriglyceridemia.

Changting Xiao1, Takehiko Watanabe, Yi Zhang, Bernardo Trigatti, Linda Szeto, Phil W Connelly, Santica Marcovina, Tomas Vaisar, Jay W Heinecke, Gary F Lewis.   

Abstract

A low level of high-density lipoprotein (HDL) cholesterol is characteristic of insulin resistance and hypertriglyceridemia and likely contributes to the increased risk of cardiovascular disease associated with these conditions. One pathway involves enhanced clearance of lipolytically modified HDL particles, but the underlying mechanisms remain poorly understood. Here, we examine the effect of triglyceride enrichment and hepatic lipase hydrolysis on HDL binding, internalization, and degradation in cultured liver and kidney cells. Maximal binding of remnant HDL (HDL enriched with triglycerides followed by hepatic lipase hydrolysis), but not binding affinity, was markedly higher than native and triglyceride-rich HDL in both HepG2 cells and HEK293 cells. Compared with native and triglyceride-rich HDL, remnant HDL was internalized to a greater extent in both cell types and was more readily degraded in HEK293 cells. The increased binding of remnant HDL was not mediated by the low-density lipoprotein receptor or scavenger receptor class B type I (SR-BI), because enhanced remnant HDL binding was observed in low-density lipoprotein receptor-deficient cells with or without SR-BI overexpression. Disruption of cell surface heparan sulfate proteoglycans or blockage of apolipoprotein E-mediated lipoprotein binding also did not abolish the enhanced remnant HDL binding. Our observations indicate that remodeling of triglyceride-enriched HDL by hepatic lipase may result in enhanced binding, internalization, and degradation in tissues involved in HDL catabolism, contributing to rapid clearance and overall lowering of plasma HDL cholesterol in insulin resistance and hypertriglyceridemia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18556574     DOI: 10.1161/CIRCRESAHA.108.178756

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  17 in total

1.  Effect of genetic variants related to lipid metabolism as risk factors for cholelithiasis after bariatric surgery in Brazilian population.

Authors:  Sidney Pinheiro-Júnior; Marcela A S Pinhel; Marcelo A Nakazone; Anielli Pinheiro; Gisele F S Amorim; Greiciane M S Florim; Camila M Mazeti; Michele L Gregório; Marina G Moschetta; Gilberto B Brito; Sérgio L A Brienze; Carla B Nonino; Antonio C Brandão; Dorotéia R S Souza
Journal:  Obes Surg       Date:  2012-04       Impact factor: 4.129

Review 2.  Lipoprotein metabolism, dyslipidemia, and nonalcoholic fatty liver disease.

Authors:  David E Cohen; Edward A Fisher
Journal:  Semin Liver Dis       Date:  2013-11-12       Impact factor: 6.115

3.  Characterization of metabolic interrelationships and in silico phenotyping of lipoprotein particles using self-organizing maps.

Authors:  Linda S Kumpula; Sanna M Mäkelä; Ville-Petteri Mäkinen; Anna Karjalainen; Johanna M Liinamaa; Kimmo Kaski; Markku J Savolainen; Minna L Hannuksela; Mika Ala-Korpela
Journal:  J Lipid Res       Date:  2009-09-05       Impact factor: 5.922

4.  Mendelian randomization reveals unexpected effects of CETP on the lipoprotein profile.

Authors:  Lisanne L Blauw; Raymond Noordam; Sebastian Soidinsalo; C Alexander Blauw; Ruifang Li-Gao; Renée de Mutsert; Jimmy F P Berbée; Yanan Wang; Diana van Heemst; Frits R Rosendaal; J Wouter Jukema; Dennis O Mook-Kanamori; Peter Würtz; Ko Willems van Dijk; Patrick C N Rensen
Journal:  Eur J Hum Genet       Date:  2018-11-12       Impact factor: 4.246

Review 5.  Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey.

Authors:  Richard Kones
Journal:  Drug Des Devel Ther       Date:  2011-06-13       Impact factor: 4.162

6.  Alteration of negatively charged residues in the 89 to 99 domain of apoA-I affects lipid homeostasis and maturation of HDL.

Authors:  Andreas K Kateifides; Irina N Gorshkova; Adelina Duka; Angeliki Chroni; Dimitris Kardassis; Vassilis I Zannis
Journal:  J Lipid Res       Date:  2011-04-19       Impact factor: 5.922

Review 7.  New molecular insights into CETP structure and function: a review.

Authors:  M Arthur Charles; John P Kane
Journal:  J Lipid Res       Date:  2012-06-07       Impact factor: 5.922

8.  Effects of weight loss, induced by gastric bypass surgery, on HDL remodeling in obese women.

Authors:  Bela F Asztalos; Michael M Swarbrick; Ernst J Schaefer; Gerard E Dallal; Katalin V Horvath; Masumi Ai; Kimber L Stanhope; Iselin Austrheim-Smith; Bruce M Wolfe; Mohamed Ali; Peter J Havel
Journal:  J Lipid Res       Date:  2010-08       Impact factor: 5.922

9.  When HDL gets fat...

Authors:  Robert J Brown; Daniel J Rader
Journal:  Circ Res       Date:  2008-07-18       Impact factor: 17.367

10.  High-density lipoprotein endocytosis in endothelial cells.

Authors:  Stefanie Fruhwürth; Margit Pavelka; Robert Bittman; Werner J Kovacs; Katharina M Walter; Clemens Röhrl; Herbert Stangl
Journal:  World J Biol Chem       Date:  2013-11-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.